Atika Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-157,000
| Closed | -$16.9M | – | 106 |
|
|
2021
Q4 | $16.9M | Sell |
157,000
-4,000
| -2% | -$431K | 1.19% | 36 |
|
|
2021
Q3 | $17.6M | Hold |
161,000
| – | – | 1.05% | 29 |
|
|
2021
Q2 | $15.1M | Buy |
161,000
+6,000
| +4% | +$562K | 1.19% | 34 |
|
|
2021
Q1 | $14.3M | Buy |
+155,000
| New | +$14.3M | 1.24% | 28 |
|
|
2020
Q4 | – | Sell |
-206,500
| Closed | -$16M | – | 141 |
|
|
2020
Q3 | $16M | Buy |
206,500
+33,500
| +19% | +$2.6M | 1.31% | 21 |
|
|
2020
Q2 | $9.62M | Buy |
+173,000
| New | +$9.62M | 1.24% | 28 |
|
|
2019
Q2 | – | Sell |
-155,000
| Closed | -$4.1M | – | 96 |
|
|
2019
Q1 | $4.1M | Buy |
+155,000
| New | +$4.1M | 0.83% | 40 |
|
|
2016
Q4 | – | Sell |
-265,000
| Closed | -$4.81M | – | 79 |
|
|
2016
Q3 | $4.81M | Sell |
265,000
-168,000
| -39% | -$3.05M | 1.96% | 14 |
|
|
2016
Q2 | $7.13M | Buy |
433,000
+193,000
| +80% | +$3.18M | 3.06% | 6 |
|
|
2016
Q1 | $3.98M | Buy |
+240,000
| New | +$3.98M | 2.4% | 17 |
|
|
2015
Q3 | – | Sell |
-129,650
| Closed | -$4.5M | – | 77 |
|
|
2015
Q2 | $4.5M | Buy |
+129,650
| New | +$4.5M | 2.03% | 11 |
|